L3 - Enterobactericiae SPP

Download as pptx, pdf, or txt
Download as pptx, pdf, or txt
You are on page 1of 23

INTRODUCTION TO

ENTEROBACTERIACEAE

Prepared by : Zakaria Ismail


Uitm Penang Kampus Bertam 2012
Learning Outcome
At the end of the lecture, student should be able to :
1- Know the morphology and physiology of
enterobactericiae.
2- Know the basic symptom and pathogenicity of
the infection of enterobactericiae.
3- Know the epidemiology of enterobactericiae
infection.
4-Identify the suitable lab diognosis,treatment and
prevention of this species.
INTRODUCTION
• Referred to as the Enterics or enteric gram
negative rods.
• Widely distributed in the environment.
• Commensal flora in the intestinal tract of
humans and other animals.
• Approximately 80% of gram negative rods
isolated from clinical specimens.
• Responsible for:
- almost 50% of cases of septicemia disease
- over 70% of urinary tract infections (UTI).
• Currently over 100 species in 27 genera have
been identified
MORPHOLOGY
 All Enterobacteriaciae:

1. Ferment glucose with acid production


2. Reduce nitrates (NO3 to NO2 or all the way to N2)
3. Oxidase negative
4. All are aerobic but can be facultatively anaerobic
5. Motile via peritrichous flagella except Shigella spp and Klebsiella
spp which are non- motile
6. Capsule, slime layer, or neither
7. Possess fimbriae (pili)
8. Biochemically and metabolically diverse; ferment glucose by the
mixed acid pathway; Klebsiella, Enterobacter and Serratia utilize the
butanediol pathway.
9. Gram-negative enteric bacilli
10. Non-spore forming except Klebsiella spp
LACTOSE FERMENTER AND
NON LACTOSE FERMENTER
ANTIGENS
1) O (somatic Ag), a heat stable
Ag located in the cell wall
2) H (flagellar Ag), a heat-labile Ag
in the flagellum
3) K (capsular Ag), a heat-labile
polysaccharide
Eg. E. coli
4) M Ag, responsible for mucoid
characteristics
Eg. Klebsiella spp.
Signs and Symptoms
Diarrhea
 E. coli, Salmonella spp, Shigella spp, Campylobacter spp

Fever
 Shigella spp, Campylobacter spp

Abdominal pain
 E. coli, Salmonella spp, Campylobacter spp

Gastroenteritis – food poisoning characterized by


vomiting and diarrhea
 Salmonella spp. Yersinia enterocolitica
PATHOGENICITY
 Endotoxin
• Lipopolysaccharide complexes which are
pyrogenic. It increase the capillary
permeability
 Exotoxin
• Enterotoxin (activates the adenylate
cyclase to cause diarrhea)
 Capsule – prevents phagocytosis
 Flagella – adheres to host cells
Differences between bacterial Endotoxin
and Exotoxin

PROPERTY ENDOTOXIN EXOTOXIN

Lipopolysaccharide (mw =
CHEMICAL NATURE Protein (mw = 50-1000kDa)
10kDa)

RELATIONSHIP TO CELL Part of outer membrane Extracellular, diffusible


DENATURED BY BOILING No Usually
ANTIGENIC Yes Yes
FORM TOXOID No Yes
POTENCY Relatively low (>100ug) Relatively high (1 ug)
SPECIFICITY Low degree High degree

Often
ENZYMATIC ACTIVITY No

PYROGENICITY Yes Occasionally


EPIDEMIOLOGY
• The Enterobacteriaceae are not only pathogens and
commensals of the mammalian gastrointestinal tract.
• They are also found in abundance in almost any moist
environment, notably soil, water, and the domestic
environment.
• Some of the normal inhabitants of the small and 
large intestine included in the family: therefore, they are
sometimes referred to as enteric bacilli or simply enteric.
• Enterics are responsible for a majority of nosocomial
 infections
• Some, like Escherichia coli, are always considered to be
of faecal origin, and exist only transiently in other
environments
• Others are natural environmental strains and
can be found among the flora associated with
growing vegetables. 
• It is possible that these environmental bacteria
contribute to normal flora via food. Raw meat
and vegetables are particularly likely to carry
large numbers of bacteria. The same E.
coli and Klebsiella spp. serotypes have been
found in food and in the patients who consumed
it.
• About two million patients per year in the United
States are estimated to acquire nosocomial
infections
• Approximately 5% to 10% of the total hospital
population acquired such infections
LABORATORY DIAGNOSIS
• Specimen:
– Pus
– Tissue
– Sputum
– Fluid
– Rectal swab
– feces
• Specimen should be cultured immediately or
placed on special media to prevent growth
Culture:
Colony morphology: moist, gray (except 
Serratia marcescans which appears red)
smooth colonies on non-selective media
Special differential and selective media used
for separation of genera and species
Some strains are beta hemolytic on blood
agar
Special isolation media: contain various
substances including indicators, inhibitors,
etc.
Biochemical test:
Identify enteric bacteria according to:
 saccharides fermentation
 gas and H2S production (TSI)
 indole production and motility test (peptone
medium)
 NH4  utilization (Simmons citrate medium),
urea fermentation (urea medium).
 Numeric identification of Enterobacteriaceae
Enterotest I, II.- the results are compared with
the Enterotest register and evaluated in a
special program.
Workflow of Enterobactericiae identification
Antimicrobial Susceptibility testing
(AST)

• Using disk diffusion method


• Cultured on Mueller Hinton Agar
• Examples of antibiotic used for identification
of enterobactericeae:
 Sulfonamide
 Trimethoprim
 Co-trimoxazole
 Ampicillin
 Nitrofurantoin
 Nalidixic acid
 Tetracyclin
TREATMENT AND PREVENTION
*Serratia spp.

Treat with either aminoglycosides,


chloramphenicol, or trimethoprimsulfa-
methoxazole; resistant to most of the
"common" antibiotics

*Enterobacter spp.

Treat with any antimicrobials used for


enterobacterial diseases
*Shigella spp.

Patients with severe dysentery are usually


treated with antibiotics (e.g. ampicillin).

*Salmonella spp.

In contrast to salmonellosis, patients


respond to antibiotic therapy and disease
duration is diminished

You might also like